1-4 of 4
Martine Sebillot
Close
Sort by
Journal Articles

Evaluation of the Concordance of Two Free Light Chains Assays to Identify High Risk Smoldering Myeloma Patients.

Caroline Moreau, Emmanuel Rouger, Basile Henriot, Martine Escoffre, Martine Sebillot, Thierry Lamy, Stéphane Minvielle, Herve Avet Loiseau, MD PhD, Olivier Decaux, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2070.
https://doi.org/10.1182/blood.V128.22.2070.2070
Published: 2016
Journal Articles

Interest of Diffusion Weighted Magnetic Resonance Imaging for the Evaluation of Bone Marrow Infiltration in Multiple Myeloma, Smoldering Myeloma and Monoclonal Gammopathy of Undetermined Significance.

Olivier Decaux, Thierry Josseaume, Eric Brillet, Thierry Lamy, Marc Bernard, Martine Escoffre, Martine Sebillot, Bernard Grosbois, Regis Duvauferrier
Journal: Blood
Blood (2009) 114 (22): 4874.
https://doi.org/10.1182/blood.V114.22.4874.4874
Published: 2009
Journal Articles

Clinical and Biological Features of Biclonal Gammopathies. Review of 203 Cases

Olivier Decaux, MD, Helene Leroy, Jean-Christophe Ianotto, MD, Annie Ruelland, MD, Lucienne Guenet, MD, Martine Sebillot, MD, Patrick Jego, MD, PhD, Bernard Grosbois, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5151.
https://doi.org/10.1182/blood.V112.11.5151.5151
Published: 2008
Journal Articles

Regular Follow-Up of MGUS Allow Early Detection of Malignant Transformation Before Severe Complications Occur.

Olivier Decaux, MD, Sophie Besnard, Antoinette Perlat, Md, Claire Cazalets, Md, Berengere Cador, Md, Martine Sebillot, Md, Patrick Jego, Md, phd, Bernard Grosbois, Md, phd
Journal: Blood
Blood (2007) 110 (11): 4774.
https://doi.org/10.1182/blood.V110.11.4774.4774
Published: 2007